Precigen, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
PGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
20374 Seneca Meadows Parkway, Germantown, Maryland

Insiders trading volume in the past year

Precigen, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Randal J. Kirk Director, 10%+ Owner $98.9M +$20.1M +25.6% Aug 9, 2024
Ares Trading S.A. 10%+ Owner $29.1M Oct 12, 2021
Helen Sabzevari President and CEO, Director $3.11M May 31, 2024
Hassan Fred Director $1.6M Mar 14, 2024
Steven Frank Director $1.59M Mar 14, 2024
Cesar L. Alvarez Director $940K Mar 14, 2024
Dean J. Mitchell Director $845K +$35.3K +4.36% Mar 14, 2024
James S. Turley Director $801K Mar 14, 2024
Vinita D. Gupta Director $772K Mar 14, 2024
Donald P. Lehr Chief Legal Officer $753K May 31, 2024
Jeffrey B. Kindler Director $688K -$136K -16.5% Mar 14, 2024
Robert B. Shapiro Director $657K Mar 9, 2023
Jeffrey T. Perez SVP, IP Affairs $632K +$50K +8.6% Aug 9, 2024
Harry Thomasian Jr. Chief Financial Officer $321K May 31, 2024
Rutul R. Shah Chief Operating Officer $294K May 31, 2024
Nancy H. Agee Director $202K Jul 5, 2024
James V. Lambert Ex. Dir. Fin., PGEN Ther. Inc. $17.4K Jun 10, 2021
Phil Tennant Chief Commercial Officer Jul 22, 2024

Recent Insider Transactions by Companies or Individuals for Precigen, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.